Butyrate
Active ingredient: Hydrocortisone Butyrate
In short: Hydrocortisone Butyrate Lotion is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.
What is Butyrate used for?
Hydrocortisone Butyrate Lotion is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.
Butyrate dosage
Apply Hydrocortisone Butyrate Lotion for up to 2 weeks as a thin layer to the affected skin two times daily and rub in gently. Discontinue Hydrocortisone Butyrate Lotion when control is achieved.
If no improvement is seen within 2 weeks, consider reassessment of the diagnosis. Before prescribing for more than 2 weeks, the additional benefits of extending treatment up to 4 weeks should be weighed against the risk of endocrine system adverse reactions and local adverse reactions .
Hydrocortisone Butyrate Lotion is not for oral, ophthalmic, or intravaginal use.
Do not use Hydrocortisone Butyrate Lotion :
o With occlusive dressings unless directed by a healthcare provider. Avoid use in the diaper area, as diapers or plastic pants may constitute occlusive dressings.
o On the face, underarms, or groin areas unless directed by a healthcare provider.
How to take Butyrate — instructions & advice from the label
Patients using Hydrocortisone Butyrate Lotion should receive the following information and instructions:
Administration Instructions
Instruct patients to apply a thin layer to the affected skin two times daily and rub in gently .
Advise patients to discontinue Hydrocortisone Butyrate Lotion when control is achieved .
Advise patients to avoid use for longer than 2 weeks. Instruct patients to contact their healthcare provider if no improvement is seen within 2 weeks .
Advise patients to
NOT
:
Bandage, otherwise cover, or wrap the affected skin area unless directed by their healthcare provider.
Use Hydrocortisone Butyrate Lotion in the diaper area, as diapers or plastic pants may constitute occlusive dressings.
Use Hydrocortisone Butyrate Lotion on the face, underarms, or groin areas unless directed by their healthcare provider.
Endocrine System Adverse Reactions
Instruct patients not to use other corticosteroid-containing products while using Hydrocortisone Butyrate Lotion without first consulting their healthcare provider
.
Ophthalmic Adverse Reactions
Advise patients to avoid contact with the eyes. Instruct patients to report any visual symptoms to their healthcare providers
. …
Warnings & precautions
Do not take this medicine if: None.
Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression
Use of topical corticosteroids, including Hydrocortisone Butyrate Lotion, can cause systemic adverse reactions including reversible hypothalamic-pituitary-adrenal (HPA) axis suppression with the potential for clinical glucocorticosteroid insufficiency. Factors that predispose a patient to HPA axis suppression include the use of high-potency steroids, large treatment surface areas, prolonged use, use of occlusive dressings, altered skin barrier, liver failure, and young age. Such patients should be considered for periodic evaluation of the HPA axis. This may be done by using cosyntropin (ACTH
1-24) stimulation testing (CST). If HPA axis suppression is noted, reduce the frequency of application or discontinue Hydrocortisone Butyrate Lotion, or substitute with a less potent corticosteroid. Signs and symptoms of glucocorticosteroid insufficiency may occur, requiring supplemental systemic corticosteroids
.
Studies conducted in pediatric subjects demonstrated reversible HPA axis suppression after use of Hydrocortisone Butyrate Lotion. Pediatric patients may be more susceptible than adults to systemic toxicity from equivalent doses of Hydrocortisone Butyrate Lotion due to their larger skin-surface-to-body-mass ratios
.
Cushing's Syndrome, Hyperglycemia, and Glucosuria
Systemic adverse reactions of topical corticosteroids, including Hydrocortisone Butyrate Lotion, may also include manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria.
Additional Considerations for Endocrine Adverse Reactions
Use of more than one corticosteroid-containing product at the same time may increase total systemic corticosteroid exposure. …
Butyrate side effects
The following adverse reactions are discussed in greater detail in other sections of the labeling:
• HPA axis suppression
• Ophthalmic Adverse Reactions
• Skin infections
• Allergic contact dermatitis
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of the drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
The safety data described below reflect Hydrocortisone Butyrate Lotion applied topically twice daily for up to 4 weeks in vehicle-controlled clinical trials of 284 pediatric subjects 3 months to 18 years of age and 301 adult subjects with mild to moderate atopic dermatitis .
The incidence of selected adverse reactions reported by ≥1% of subjects during the studies is presented in
Table 1 and
Table 2.
Hydrocortisone Butyrate Lotion
(n=139) n (%) | Vehicle
(n=145) n (%)
Application site reactions, including application site burning, pruritus, dermatitis, erythema, eczema, inflammation, or irritation | 2 (1) | 20 (14)
Infantile acne | 1 (1) | 0 (0)
Skin depigmentation | 1 (1) | 0 (0)
Hydrocortisone Butyrate
Lotion
(n=151) n (%) | Vehicle
(n=150) n (%)
Application site reactions, including application site burning, dermatitis, eczema, erythema, or pruritus | 5 (3) | 7 (5)
The following adverse reactions have been identified during postapproval use of topical corticosteroids, including Hydrocortisone Butyrate Lotion. …
About this medicine
Hydrocortisone Butyrate Lotion, 0.1% contains hydrocortisone butyrate, a non-fluorinated hydrocortisone ester, for topical use.
Hydrocortisone butyrate is a corticosteroid.
The chemical name of hydrocortisone butyrate is Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-[(1-oxobutyl)oxy(11β)-]. It has the following structural formula:
Hydrocortisone butyrate is a white to off-white powder with a molecular weight of 432.56, and a molecular formula of C
25H
36O
6. It is practically insoluble in water, slightly soluble in ether, soluble in methanol, alcohol, and acetone, and freely soluble in chloroform.
Each gram of Hydrocortisone Butyrate Lotion contains 1 mg of hydrocortisone butyrate in a white to off-white lotion base consisting of anhydrous citric acid, ceteth-20, cetostearyl alcohol, butylated hydroxytoluene (BHT), butylparaben, light mineral oil, propylparaben, purified water, sodium citrate, and white petrolatum. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID ce135638-e551-4bb0-bd2b-f97d381a8c7c. Read the full official label on DailyMed.
Related medicines
Doxycycline Adalimumab Ketoconazole Levocetirizine Cyclosporine Tretinoin Brimonidine Dupilumab